Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications, Arthritis Research, vol.2, issue.1, pp.33-37, 2000. ,
DOI : 10.1186/ar67
Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis, Osteoporosis International, vol.1192, issue.Suppl 3, pp.1023-1036, 2011. ,
DOI : 10.1007/s00198-010-1462-4
Production by Cultured Alveolar Macrophages from Normal Human Donors and from Patients with Pulmonary Sarcoidosis*, The Journal of Clinical Endocrinology & Metabolism, vol.65, issue.6, pp.1201-1209, 1987. ,
DOI : 10.1210/jcem-65-6-1201
Clinical impact of bone and calcium metabolism changes in sarcoidosis, Thorax, vol.53, issue.5, pp.425-429, 1998. ,
DOI : 10.1136/thx.53.5.425
Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism., Journal of Clinical Investigation, vol.66, issue.4, pp.852-855, 1980. ,
DOI : 10.1172/JCI109924
Reversibility of exogenous corticosteroid-induced bone loss, Eur Respir J, vol.6, pp.116-119, 1993. ,
Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility, pp.89-92, 1990. ,
Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women, Sarcoidosis, vol.5, pp.93-98, 1988. ,
Bone mineral density in women with sarcoidosis, J Bone Miner Metab, vol.22, pp.48-52, 2004. ,
Glucocorticoid-Induced Osteoporosis in Patients with Sarcoidosis, The American Journal of the Medical Sciences, vol.325, issue.1, pp.1-6, 2003. ,
DOI : 10.1097/00000441-200301000-00001
Bone loss in prednisone treated sarcoidosis: a two-year follow-up, Ann Ital Med Int, vol.5, pp.164-168, 1990. ,
Researching osteoporosis in prednisone treated sarcoid patients, Sarcoidosis, vol.4, pp.45-48, 1987. ,
Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study, Osteoporosis International, vol.15, issue.6, pp.839-847, 2008. ,
DOI : 10.1016/8756-3282(94)90822-2
Evaluation of the calcium content of diet by frequential self-questionnaire, Rev Rhum Mal Osteoartic, vol.58, pp.99-103, 1991. ,
Vertebral fracture assessment using a semiquantitative technique, Journal of Bone and Mineral Research, vol.13, issue.S1, pp.1137-1148, 1993. ,
DOI : 10.1002/jbmr.5650080915
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.1, pp.53-58, 2011. ,
DOI : 10.1210/jc.2010-2704
Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis, Respiratory Medicine, vol.104, issue.4, pp.564-570, 2010. ,
DOI : 10.1016/j.rmed.2009.12.004
Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women, JAMA, vol.303, issue.18, pp.815-822, 2010. ,
DOI : 10.1001/jama.2010.594
The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass???a randomized controlled 1-year trial, Osteoporosis International, vol.303, issue.1, pp.201-211, 2012. ,
DOI : 10.1007/s00198-011-1752-5
Circulating 25-Hydroxyvitamin D Levels and Frailty Status in Older Women, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.12, pp.5266-5273, 2010. ,
DOI : 10.1210/jc.2010-2317
High-Dose Vitamin D Supplementation, JAMA, vol.303, issue.18, pp.1861-1862, 2010. ,
DOI : 10.1001/jama.2010.598
In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH, Journal of Cellular Biochemistry, vol.8, issue.2, pp.267-277, 2003. ,
DOI : 10.1002/jcb.10623
Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts, The Journal of Steroid Biochemistry and Molecular Biology, vol.121, issue.1-2, pp.71-75, 2010. ,
DOI : 10.1016/j.jsbmb.2010.03.021
Bone mineral density and vitamin D in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, pp.219-223, 1999. ,
Relative Value of 25(OH)D and 1,25(OH)2D Measurements, Journal of Bone and Mineral Research, vol.145, issue.90, pp.1668-1671, 2007. ,
DOI : 10.1359/jbmr.070716
Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNF?? blockade: results from a prospective cohort study, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.1165-1167, 2011. ,
DOI : 10.1136/ard.2010.137265
Extraskeletal effects of vitamin??D: Facts, uncertainties, and controversies, Joint Bone Spine, vol.78, issue.1, pp.10-16, 2011. ,
DOI : 10.1016/j.jbspin.2010.10.011
Calcium and vitamin D metabolism in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, vol.1, pp.113-120, 2013. ,
The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study, Journal of Bone and Mineral Research, vol.10, issue.6, pp.1051-1056, 2002. ,
DOI : 10.1359/jbmr.2002.17.6.1051
Vertebral Fractures and Role of Low Bone Mineral Density in Crohn???s Disease, Clinical Gastroenterology and Hepatology, vol.5, issue.6, pp.721-728, 2007. ,
DOI : 10.1016/j.cgh.2007.02.024
Bone turnover and hip bone mineral density in patient with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, pp.51-58, 2007. ,